Cover Image
市場調查報告書

Teikoku Pharma USA, Inc. :產品平台分析

Teikoku Pharma USA, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 201003
出版日期 內容資訊 英文 31 Pages
訂單完成後即時交付
價格
Back to Top
Teikoku Pharma USA, Inc. :產品平台分析 Teikoku Pharma USA, Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 31 Pages
簡介

Teikoku Pharma USA, Inc. ha是是研發及製造外皮用藥產品之製藥公司。此外該公司的研發部門也在開發著治療背痛、老年癡呆症、橫向上髁炎、突發性疼痛、CINV、PHN等疾病的治療藥。

本報告提供Teikoku Pharma USA, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Teikoku Pharma USA, Inc.的基本資料

  • Teikoku Pharma USA, Inc.概要
  • 主要資訊
  • 企業資料

Teikoku Pharma USA, Inc.:R&D概要

  • 主要的治療範圍

Teikoku Pharma USA, Inc.:評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Teikoku Pharma USA, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Teikoku Pharma USA, Inc.:藥物簡介

  • flurbiprofen
  • TPM-189
  • TPW-182
  • TPW-196
  • TPW-146

Teikoku Pharma USA, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Teikoku Pharma USA, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07377CDB

Summary

Global Markets Direct's, 'Teikoku Pharma USA, Inc. - Product Pipeline Review - 2015', provides an overview of the Teikoku Pharma USA, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Teikoku Pharma USA, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Teikoku Pharma USA, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Teikoku Pharma USA, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Teikoku Pharma USA, Inc.'s pipeline products

Reasons to buy

  • Evaluate Teikoku Pharma USA, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Teikoku Pharma USA, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Teikoku Pharma USA, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Teikoku Pharma USA, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Teikoku Pharma USA, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Teikoku Pharma USA, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Teikoku Pharma USA, Inc. Snapshot
    • Teikoku Pharma USA, Inc. Overview
    • Key Information
    • Key Facts
  • Teikoku Pharma USA, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Teikoku Pharma USA, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Teikoku Pharma USA, Inc. - Pipeline Products Glance
    • Teikoku Pharma USA, Inc. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
    • Teikoku Pharma USA, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Teikoku Pharma USA, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Teikoku Pharma USA, Inc. - Drug Profiles
    • docetaxel
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • flurbiprofen sodium
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPM-189
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPW-182
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPW-196
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPU-006
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPU-010
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPU-011
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPW-146
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Teikoku Pharma USA, Inc. - Pipeline Analysis
  • Teikoku Pharma USA, Inc. - Pipeline Products by Target
  • Teikoku Pharma USA, Inc. - Pipeline Products by Route of Administration
  • Teikoku Pharma USA, Inc. - Pipeline Products by Molecule Type
  • Teikoku Pharma USA, Inc. - Pipeline Products by Mechanism of Action
  • Teikoku Pharma USA, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Teikoku Pharma USA, Inc., Key Information
  • Teikoku Pharma USA, Inc., Key Facts
  • Teikoku Pharma USA, Inc. - Pipeline by Indication, 2015
  • Teikoku Pharma USA, Inc. - Pipeline by Stage of Development, 2015
  • Teikoku Pharma USA, Inc. - Monotherapy Products in Pipeline, 2015
  • Teikoku Pharma USA, Inc. - Partnered Products in Pipeline, 2015
  • Teikoku Pharma USA, Inc. - Partnered Products/ Combination Treatment Modalities, 2015
  • Teikoku Pharma USA, Inc. - Pre-Registration, 2015
  • Teikoku Pharma USA, Inc. - Phase II, 2015
  • Teikoku Pharma USA, Inc. - Phase I, 2015
  • Teikoku Pharma USA, Inc. - Preclinical, 2015
  • Teikoku Pharma USA, Inc. - Pipeline by Target, 2015
  • Teikoku Pharma USA, Inc. - Pipeline by Route of Administration, 2015
  • Teikoku Pharma USA, Inc. - Pipeline by Molecule Type, 2015
  • Teikoku Pharma USA, Inc. - Pipeline Products by Mechanism of Action, 2015

List of Figures

  • Teikoku Pharma USA, Inc. - Pipeline by Top 10 Indication, 2015
  • Teikoku Pharma USA, Inc. - Pipeline by Stage of Development, 2015
  • Teikoku Pharma USA, Inc. - Monotherapy Products in Pipeline, 2015
  • Teikoku Pharma USA, Inc. - Pipeline by Top 10 Target, 2015
  • Teikoku Pharma USA, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Teikoku Pharma USA, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Teikoku Pharma USA, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top